[Quality of life for patients treated for head and neck carcinoma]
- PMID: 20724192
- DOI: 10.1016/j.canrad.2010.06.008
[Quality of life for patients treated for head and neck carcinoma]
Abstract
A large consensus admits that quality of life is a multifactorial concept including at least physical, psychical and social dimensions of the disease as well as symptoms related to the disease and to the requested treatments. Quality of life is actually considered as one of the major assessment criteria for taking care of patients with cancer and to evaluate results of clinical trials. Self-evaluation by the patient is considered as the gold standard to evaluate the clinical symptoms. This evaluation is not unambiguous. Medical doctors underestimate patients' symptoms. In the field of surgery, development of organ preservation strategies should be considered as one of the major improvement observed in the modern era of head and neck oncology. The role of xerostomia, the most frequent complication reported after head and neck radiation therapy, is major in this field. However, odynophagia is considered as the most detrimental component of quality of life. Radiation oncologists should realize the role of these parameters in order to include these concepts as relevant in the global evaluation of treatments.
Copyright © 2010 Société française de radiothérapie oncologique (SFRO). Published by Elsevier SAS. All rights reserved.
Similar articles
-
Impact of late treatment-related toxicity on quality of life among patients with head and neck cancer treated with radiotherapy.J Clin Oncol. 2008 Aug 1;26(22):3770-6. doi: 10.1200/JCO.2007.14.6647. J Clin Oncol. 2008. PMID: 18669465 Clinical Trial.
-
Toxicity and compliance of subcutaneous amifostine in patients undergoing postoperative intensity-modulated radiation therapy for head and neck cancer.Semin Oncol. 2004 Dec;31(6 Suppl 18):8-12. doi: 10.1053/j.seminoncol.2004.12.005. Semin Oncol. 2004. PMID: 15726516 Clinical Trial.
-
Intensity-modulated radiotherapy reduces radiation-induced morbidity and improves health-related quality of life: results of a nonrandomized prospective study using a standardized follow-up program.Int J Radiat Oncol Biol Phys. 2009 May 1;74(1):1-8. doi: 10.1016/j.ijrobp.2008.07.059. Epub 2008 Dec 26. Int J Radiat Oncol Biol Phys. 2009. PMID: 19111400
-
Evaluation, prevention and management of radiotherapy-induced xerostomia in head and neck cancer patients.Curr Opin Oncol. 2006 May;18(3):266-70. doi: 10.1097/01.cco.0000219256.37843.83. Curr Opin Oncol. 2006. PMID: 16552239 Review.
-
Organ preservation in patients with squamous cancers of the head and neck.Surg Oncol Clin N Am. 2004 Jan;13(1):187-99. doi: 10.1016/S1055-3207(03)00120-0. Surg Oncol Clin N Am. 2004. PMID: 15062369 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical